Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-51087.47%
operating margin TTM
-88279.72%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -0.83 |
| peg ratio | 0.00 |
| price to book ratio | 2.99 |
| price to sales ratio | 585.76 |
| enterprise value multiple | -0.91 |
| price fair value | 2.99 |
profitability ratios | |
|---|---|
| gross profit margin | 83.42% |
| operating profit margin | -88279.72% |
| pretax profit margin | -50480.64% |
| net profit margin | -51087.47% |
| return on assets | -123.69% |
| return on equity | 3328.97% |
| return on capital employed | -484.28% |
liquidity ratio | |
|---|---|
| current ratio | 1.37 |
| quick ratio | 1.37 |
| cash ratio | 0.96 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 0.00 |
| receivables turnover | 0.00 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 0.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | -8.27 |
| cash per share | 1.86 |
| operating cash flow per share | -8.10 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | 0.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -48.64 |
Frequently Asked Questions
When was the last time BriaCell Therapeutics Corp. (NASDAQ:BCTX) reported earnings?
BriaCell Therapeutics Corp. (BCTX) published its most recent earnings results on 31-10-2024.
What is BriaCell Therapeutics Corp.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. BriaCell Therapeutics Corp. (NASDAQ:BCTX)'s trailing twelve months ROE is 3328.97%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. BriaCell Therapeutics Corp. (BCTX) currently has a ROA of -123.69%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BCTX's net profit margin stand at?
BCTX reported a profit margin of -51087.47% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BCTX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.37 in the most recent quarter. The quick ratio stood at 1.37, with a Debt/Eq ratio of 0.00.